Gilead Sciences, Inc. (GILD)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

Gilead Sciences, Inc. (GILD) is up 3.0% since the beginning of the year. At $125 per share, GILD is trading 20.6% below its 52-week high of $157. Investors who bought $1,000 worth of GILD shares 5 years ago would now be looking at an investment worth $2,248.

Gilead Sciences, Inc. (GILD) has returned 2.99% so far this year and 18.09% over the past 12 months. Over the last ten years, GILD has returned 8.26% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.

Based on dividend-adjusted daily data since Jan 22, 1992, GILD's average daily return is +0.11%, while the average monthly return is +2.05%. At this rate, an investment would double in approximately 2.8 years.

Historically, 55% of months were positive and 45% were negative. The best month was Feb 2000 with a return of +63.4%, while the worst month was Jun 1996 at -31.4%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 7 months.

On a daily basis, GILD closed higher 50% of trading days. The best single day was Apr 28, 2000 with a return of +24.8%, while the worst single day was Jul 15, 1996 at -26.6%.

Gilead Sciences, Inc. has an annualized alpha of 21.00%, beta of 0.87, and R2 of 0.11 versus S&P 500 Index. Calculated based on daily prices since January 22, 1992.

• This stock captured 101.36% of S&P 500 Index gains but only 53.73% of its losses - a favorable profile for investors.
• R2 of 0.11 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

GILD ranks 61 for risk / return — better than 61% of stocks on our site. You're getting solid returns for the risk taken. A good sign, especially for investors who want growth without excessive volatility.

Gilead Sciences, Inc. provided a 2.58% dividend yield over the last twelve months, with an annual payout of $3.22 per share. The company has been increasing its dividends for 10 consecutive years.

The table displays the monthly dividend distributions for Gilead Sciences, Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Gilead Sciences, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Gilead Sciences, Inc. was 70.83%, occurring on Jun 6, 1994. Recovery took 300 trading sessions.

The current Gilead Sciences, Inc. drawdown is 18.87%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Gilead Sciences, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Gilead Sciences, Inc. is priced in the market compared to other companies in the Drug Manufacturers - General industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.